- Category
- Micro (2024-25)
- Udyam number
- UDYAM-BR-26-0055774

Yeager Pharmaceuticals Private Limited
About Yeager Pharmaceuticals Private Limited
Data last updated:
Yeager Pharmaceuticals Private Limited is a private limited company based in Solan, Himachal Pradesh, India. It operates in the household goods segment of the home appliances and consumer durables sector. It was incorporated on 27 April 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U51397HP2020PTC007871.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1.2 Lakh. It is led by directors including Mustari Khatun and Ajeet Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Monika Jain Plot No – 30 Basol, Solan, Himachal Pradesh, India – 173209.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.08 Lakh, a decline of 76% compared to the previous year. For the same year it recorded a net loss of ₹4,581 (net margin -2.2%) and EBITDA of ₹45,012 (EBITDA margin 21.7%). Revenue has declined at a compounded annual rate (CAGR) of 40% over three years.
As per MCA filings, the company has open charges of ₹5 Lakh on record.
Yeager Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0055774).
Company details
Recognitions & Rankings of Yeager Pharmaceuticals
Contact details
Yeager Pharmaceuticals Private Limited's registered office is in Solan, Himachal Pradesh.
- Registered AddressC/O Monika Jain Plot No – 30 Basol, Solan, Himachal Pradesh, India – 173209
- IndustryHome Appliances, Household Goods, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Yeager Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Yeager Pharmaceuticals Private Limited, buy the company report.
Financials of Yeager Pharmaceuticals Private Limited
FY 2025 filings availableYeager Pharmaceuticals Private Limited reported revenue of ₹2.08 Lakh (down 76% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 40% over three years, including a 76% fall in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹45,012 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4,581 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.7% | ||||
| Net Profit Margin | -2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Yeager Pharmaceuticals Private Limited, buy the company report.
Board of directors of Yeager Pharmaceuticals Private Limited
Yeager Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mustari Khatun | Director | 25 Aug 2021 | 5 Years 2 Months | Current |
| Ajeet Kumar Also directs: Aleos Life Sciences Private Limited | Director | 27 Apr 2020 | 6 Years 6 Months | Current |
| Tabassum Jahan | Director | 27 Apr 2020 | 6 Years 6 Months | Current |
| Lovely Singh Also directs: Aleos Life Sciences Private Limited | Director | 27 Apr 2020 | 6 Years 6 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Nov 2022 | 100659428 | Others | ₹5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Yeager Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Yeager Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Yeager Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Yeager Pharmaceuticals Private Limited has 4 board changes on record since 2020: 4 appointments. The latest: Mustari Khatun was appointed as Director on 25 Aug 2021.
Frequently asked questions
Yeager Pharmaceuticals is an active private limited company based in Solan, Himachal Pradesh, India. The company works in household goods, within the home appliances industry. It was incorporated on 27 April 2020 (6+ years old) and is registered under CIN U51397HP2020PTC007871.
Yeager Pharmaceuticals has 4 current directors:
- Mustari Khatun - Director
- Ajeet Kumar - Director
- Tabassum Jahan - Director
- Lovely Singh - Director
The latest financial statements of Yeager Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Yeager Pharmaceuticals is U51397HP2020PTC007871. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yeager Pharmaceuticals was incorporated on 27 April 2020, making it 6+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
Mustari Khatun was appointed as Director on 25 Aug 2021. Ajeet Kumar was appointed as Director on 27 Apr 2020. Lovely Singh was appointed as Director on 27 Apr 2020. Yeager Pharmaceuticals has 4 board changes on record in total.
Yes, Yeager Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0055774).
The registered office of Yeager Pharmaceuticals is at CO Monika Jain Plot No – 30 Basol, Solan, Himachal Pradesh, India – 173209.
Yeager Pharmaceuticals operates in the home appliances industry, in the household goods segment.
Yeager Pharmaceuticals has open charges of ₹5 Lakh and no satisfied charges on record as per latest MCA filings.

